Dissecting the Genetic Code of SARS-CoV-2 with Reverse Genetics

The COVID-19 pandemic has increased SARS-CoV-2 research globally resulting in three publicly available vaccines from Moderna, Pfizer (mRNA-based), and Johnson & Johnson (viral vector-based).